|
|
|
41
|
6691AD
|
QLAIRA TAB (BSP) ESTRADIOL/DIENOGEST (C)
|
DIENOGEST|ESTRADIOL
|
QLAIRA
|
28'S
|
C
|
27.18
|
0.9708
|
TAB
|
0
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
681604
|
ESTROGENS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ESTROGENS
|
|
|
|
|
42
|
6691AD
|
QLAIRA 3MG|3MG TAB (BSP) DIENOGEST (C)
|
DIENOGEST|ESTRADIOL
|
QLAIRA
|
28'S
|
C
|
22.89
|
0.82
|
TAB
|
0
|
BLIS
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
681604
|
ESTROGENS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ESTROGENS
|
|
|
|
|
40
|
6691AE
|
QLAIRA TAB (BSP/AHI) ESTRADIOL/DIENOGEST
|
DIENOGEST|ESTRADIOL
|
QLAIRA
|
28'S
|
C
|
27.18
|
0.97
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
681604
|
ESTROGENS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
6691AE
|
QLAIRA TAB (BSP) ESTRADIOL/DIENOGEST (C)
|
DIENOGEST|ESTRADIOL
|
QLAIRA
|
28'S
|
C
|
27.18
|
0.9708
|
TAB
|
0
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
681604
|
ESTROGENS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ESTROGENS
|
|
|
|
|
42
|
6691AE
|
QLAIRA 3MG|3MG TAB (BSP) DIENOGEST|ESTRADIOL
|
DIENOGEST|ESTRADIOL
|
QLAIRA
|
28'S
|
C
|
25.14
|
0.90
|
TAB
|
0
|
BLIS
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
681604
|
ESTROGENS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ESTROGENS
|
|
|
|
|
40
|
6691AF
|
BILIVE 1MG E/2MG D TAB (ABB/PHA) ESTRADIOL/DR
|
DROSPIRENONE|ETHINYL ESTRADIOL
|
BILIVE
|
30'S
|
C
|
29.98
|
1.00
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6812
|
CONTRACEPTIVES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
6691AF
|
BILIVE 1MG E/2MG D TAB (ABB/PHA) ESTRADIOL/DR (C)
|
DROSPIRENONE|ETHINYL ESTRADIOL
|
BILIVE
|
30'S
|
C
|
29.98
|
0.9993
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
681604
|
ESTROGENS
|
2022-04-01
|
2023-04-13
|
Delete from contract
|
Oral
|
0
|
ESTROGENS
|
2023-03-02
|
|
|
|
40
|
6691AH
|
ESTROTAB 2MG TAB (ABB/PHA) OESTRADIOL
|
OESTRADIOL
|
ESTROTAB
|
30'S
|
C
|
12.91
|
12.91
|
TABLET
|
0
|
PACK
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
681604
|
ESTROGENS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
6691AH
|
ESTROTAB 2MG TAB (ABB/PHA) OESTRADIOL (C)
|
OESTRADIOL
|
ESTROTAB
|
30'S
|
C
|
12.91
|
12.91
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
681604
|
ESTROGENS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
0
|
ESTROGENS
|
2023-03-07
|
|
|
|
40
|
6691AJ
|
ESTROTAB 1MG PACK (ABB/PHA) OESTRADIOL
|
OESTRADIOL
|
ESTROTAB
|
30'S
|
C
|
10.33
|
10.33
|
PACK
|
0
|
PACK
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
681604
|
ESTROGENS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
6691AJ
|
ESTROTAB 1MG PACK (ABB/PHA) OESTRADIOL (C)
|
OESTRADIOL
|
ESTROTAB
|
30'S
|
C
|
10.33
|
10.33
|
PACK
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
681604
|
ESTROGENS
|
2022-04-01
|
2023-03-31
|
Change Local Agent
|
Oral
|
0
|
ESTROGENS
|
2023-03-07
|
|
|
|
41
|
6691AK
|
VISANNE 2MG TAB (BSP) DIENOGEST (C)
|
DIENOGEST
|
VISANNE
|
28'S
|
C
|
108.73
|
3.8833
|
TAB
|
0
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6812
|
CONTRACEPTIVES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CONTRACEPTIVES
|
|
|
|
|
42
|
6691AK
|
VISANNE 2MG TAB (BSP) DIENOGEST
|
DIENOGEST
|
VISANNE
|
28'S
|
C
|
92.42
|
3.30
|
TAB
|
0
|
BLIS
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6812
|
CONTRACEPTIVES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
CONTRACEPTIVES
|
|
|
|
|
41
|
6691AL
|
VISANNE 2MG TAB (BSP) DIENOGEST (C)
|
DIENOGEST
|
VISANNE
|
28'S
|
C
|
108.73
|
3.8833
|
TAB
|
0
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
6812
|
CONTRACEPTIVES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
CONTRACEPTIVES
|
|
|
|
|
42
|
6691AL
|
VISANNE 2MG TAB (BSP) DIENOGEST
|
DIENOGEST
|
VISANNE
|
28'S
|
C
|
84.10
|
3.00
|
TAB
|
0
|
BLIS
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
6812
|
CONTRACEPTIVES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
CONTRACEPTIVES
|
|
|
|
|
40
|
6691K
|
PROGYNOVA 1MG TAB (BSP/AHI) OESTRADIOL
|
OESTRADIOL
|
PROGYNOVA
|
28'S
|
A
|
10.33
|
10.33
|
TABLET
|
1
|
PACK
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
681604
|
ESTROGENS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
6691K
|
PROGYNOVA 1MG TAB (BSP) OESTRADIOL
|
OESTRADIOL
|
PROGYNOVA
|
28'S
|
A
|
10.33
|
10.3296
|
PACK
|
1
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
681604
|
ESTROGENS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ESTROGENS
|
|
|
|
|
40
|
6691L
|
PROGYNOVA 2MG TAB (BSP/AHI) OESTRADIOL
|
OESTRADIOL
|
PROGYNOVA
|
28'S
|
A
|
11.96
|
11.96
|
TABLET
|
1
|
PACK
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
681604
|
ESTROGENS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
6691L
|
PROGYNOVA 2MG TAB (BSP) OESTRADIOL
|
OESTRADIOL
|
PROGYNOVA
|
28'S
|
A
|
11.96
|
11.9606
|
PACK
|
1
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
681604
|
ESTROGENS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ESTROGENS
|
|
|
|
|
41
|
6691M
|
ANGELIQ 1MG E/2MG D TAB (BSP) ESTRADIOL/ (C)
|
DROSPIRENONE|ESTRADIOL
|
ANGELIQ
|
28'S
|
C
|
26.61
|
26.6124
|
PACK
|
0
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
681604
|
ESTROGENS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ESTROGENS
|
|